Global Blood Glucose Monitoring Market is expected to foresee significant growth. APAC to lead the growth!

• Vikas Kumar
• February 13, 2023
• HEALTHCARE, NEWS
• Asia-Pacific Blood Glucose Monitoring Market, Blood Glucose Monitoring, Blood Glucose Monitoring Market, Blood Glucose Monitoring Market analysis, Blood Glucose Monitoring Market forecast, Blood Glucose Monitoring Market growth, Blood Glucose Monitoring Market share, Blood Glucose Monitoring Market size, Blood Glucose Monitoring Market trend, Canada Blood Glucose Monitoring Market, China Blood Glucose Monitoring Market, Europe Blood Glucose Monitoring Market, France Blood Glucose Monitoring Market, Germany Blood Glucose Monitoring Market, India Blood Glucose Monitoring Market, Italy Blood Glucose Monitoring Market, Japan Blood Glucose Monitoring Market, North America Blood Glucose Monitoring Market, Rest of Asia-Pacific Blood Glucose Monitoring Market, Rest of Europe Blood Glucose Monitoring Market, Rest of North America Blood Glucose Monitoring Market, Rest of World Blood Glucose Monitoring Market, Spain Blood Glucose Monitoring Market, U.K. Blood Glucose Monitoring Market, U.S. Blood Glucose Monitoring Market
• 0 Comments

The Blood Glucose Monitoring Market is expected to grow at a growth rate of around 7% during the forecast period (2022-2028) owing to the rising incidence of diabetes and the increasing geriatric population prone to diabetes and increasing awareness regarding diabetic prevention care is fueling the growth in blood glucose monitoring market. According to the estimations of the International Diabetes Federation (IDF), in 2021, around 537 million adults were suffering from diabetes, and it is projected to reach around 783 million by 2045. With the increasing prevalence of diabetic patients globally, it is critical for patients to regularly monitor their blood glucose levels to avoid an episode of hyperglycemia.

Request for a sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=34714

Based on product type, the blood glucose monitoring market is segmented into self-monitoring blood glucose (SMBG) and continuous glucose monitoring (CGM). Self-monitoring blood glucose devices accounted for the largest share of revenue in 2020. Easy availability of self-monitoring blood glucose devices, high consumer awareness, ease of use, low cost, accurate and immediate feedback, and reimbursement policies in some countries contribute to the demand for self-monitoring.

Based on modality, the blood glucose monitoring market is segmented into wearable and non-wearable segments. The non-wearable segment held a significant share of the market and is likely to register higher growth during the forecasted period due to painless procedures and ease of application, advanced technology, and the presence of numerous market players with strong portfolios. For instance, in 2020, Samsung collaborated with experts from the Massachusetts Institute of Technology (MIT) to unveil a non-invasive method for measuring blood sugar levels.

For a detailed analysis of the Global Blood Glucose Monitoring Market browse through- https://univdatos.com/report/blood-glucose-monitoring-market/

For a better understanding of the market adoption of the blood glucose monitoring industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America held the largest share in the blood glucose monitoring market, due to the large patient pool, well-established healthcare facilities, new product launches, and wide acceptance of advanced technologies. According to International Diabetes Federation (IDF), 51 million adults (20-79) are living with diabetes in the North America and Caribbean Region in 2021. This figure is estimated to increase to 57 million by 2030 and 63 million by 2045.

Some of the major players operating in the market include Abbott; B. Braun SE; DexCom, Inc.; Ascensia Diabetes Care Holdings AG; Medtronic plc; F. Hoffmann-La Roche Ltd.; Terumo Corporation; LifeScan IP Holdings, LLC; Senseonics; OMRON Corporation

Global Blood Glucose Monitoring Market Segmentation

Market Insight, by Product Type

• Self-Monitoring Blood Glucose (SMBG)
• Continuous Glucose Monitoring (CGM)

Market Insight, by Modality Type

• Wearable
• Non-Wearable         

Market Insight, by Distribution Channel

• Institutional
• Retail

Market Insight, by Region

• North America
  •  US
  •  Canada
  •  Rest of North America
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
• Rest of the World

Top Company Profiles

• Abbott
• B. Braun SE
• DexCom, Inc.
• Ascensia Diabetes Care Holdings AG
• Medtronic plc
• F. Hoffmann-La Roche Ltd.
• Terumo Corporation
• LifeScan IP Holdings, LLC
• Senseonics
• OMRON Corporation